Takeda Pharmaceutical
TAK
#498
Rank
ยฃ35.43 B
Marketcap
ยฃ10.65
Share price
-0.70%
Change (1 day)
1.09%
Change (1 year)

Revenue for Takeda Pharmaceutical (TAK)

Revenue in 2025 (TTM): ยฃ22.44 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current revenue (TTM ) is ยฃ22.17 Billion. In 2024 the company made a revenue of ยฃ23.84 Billion an increase over the revenue in the year 2023 that were of ยฃ23.04 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Takeda Pharmaceutical from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ22.44 B-5.86%
2024 ยฃ23.84 B3.45%
2023 ยฃ23.04 B-5.92%
2022 ยฃ24.49 B6.97%
2021 ยฃ22.90 B3.37%
2020 ยฃ22.15 B-2.16%
2019 ยฃ22.64 B78.02%
2018 ยฃ12.72 B8.04%
2017 ยฃ11.77 B-9.08%
2016 ยฃ12.94 B26.45%
2015 ยฃ10.24 B-0.89%
2014 ยฃ10.33 B2.35%
2013 ยฃ10.09 B-15.26%
2012 ยฃ11.91 B0.18%
2011 ยฃ11.89 B11.55%
2010 ยฃ10.65 B11.02%
2009 ยฃ9.60 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
ยฃ69.20 B 212.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ35.69 B 60.94%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
ยฃ47.15 B 112.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ42.33 B 90.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
ยฃ1.72 B-92.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
ยฃ2.97 B-86.60%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
ยฃ27.01 B 21.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ31.80 B 43.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ48.24 B 117.53%๐Ÿ‡บ๐Ÿ‡ธ USA